Haemonetics (HAE) EBT (2009 - 2026)

Haemonetics' EBT history runs 18 years deep, the most recent figure standing at -$28.4 million for Q1 2026.

• On a quarterly basis, EBT fell 140.15% year-over-year to -$28.4 million in Q1 2026; TTM through Mar 2026 was $128.0 million, a 39.63% decrease from a year earlier, with the FY2026 full-year figure at $128.0 million, down 39.63% from the prior year.
• EBT eased to -$28.4 million in Q1 2026 per HAE's latest filing, from $60.0 million in the prior quarter.
• Across five years, EBT topped out at $70.7 million in Q1 2025 and bottomed at -$28.4 million in Q1 2026.
• The 5-year median for EBT is $43.1 million (2022), against an average of $37.8 million.
• Across the five-year window, EBT surged 947.54% in 2022 and tumbled 140.15% in 2026, its largest moves.
• Year by year, EBT stood at $42.2 million in 2022, then grew by 4.27% to $44.0 million in 2023, then gained by 13.37% to $49.9 million in 2024, then rose by 20.15% to $60.0 million in 2025, then sank by 147.35% to -$28.4 million in 2026.
• Per Business Quant, the three latest HAE EBT figures stand at -$28.4 million (Q1 2026), $60.0 million (Q4 2025), and $51.3 million (Q3 2025).